Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epirubicin”

235 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 235 results

Testing effectiveness (Phase 2)Study completedNCT02307227
What this trial is testing

Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors

Who this might be right for
Breast Neoplasms
Centro di Riferimento Oncologico - Aviano 46
Testing effectiveness (Phase 2)Ended earlyNCT00198172
What this trial is testing

Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors

Who this might be right for
Germ Cell Tumor
Indiana University 37
Testing effectiveness (Phase 2)Study completedNCT00110695
What this trial is testing

Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer

Who this might be right for
Breast Neoplasms
NSABP Foundation Inc 66
Testing effectiveness (Phase 2)UnknownNCT05816694
What this trial is testing

The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.

Who this might be right for
Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma
Peng Liu 50
Testing effectiveness (Phase 2)UnknownNCT00496795
What this trial is testing

Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer

Who this might be right for
Stage III Breast Cancer AJCC V7
University of Bergen 100
Testing effectiveness (Phase 2)Ended earlyNCT01830270
What this trial is testing

Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer

Who this might be right for
Stomach NeoplasmsOesophageal Junction CancerLower Oesophagus Cancer
Centre Hospitalier Universitaire de Besancon 30
Testing effectiveness (Phase 2)UnknownNCT00033683
What this trial is testing

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom
Testing effectiveness (Phase 2)UnknownNCT00218205
What this trial is testing

Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Department of Veterans Affairs, New Jersey 28
Testing effectiveness (Phase 2)Study completedNCT01630083
What this trial is testing

Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer

Who this might be right for
CLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of EsophagusCLDN18.2-positive Gastric Adenocarcinoma
Astellas Pharma Global Development, Inc. 252
Early research (Phase 1)Study completedNCT00878904
What this trial is testing

Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of California, San Francisco 40
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)UnknownNCT03507465
What this trial is testing

Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Guangdong Provincial People's Hospital 290
Large-scale testing (Phase 3)Study completedNCT00544232
What this trial is testing

Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 720
Large-scale testing (Phase 3)UnknownNCT00843934
What this trial is testing

Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Nihon University 450
Large-scale testing (Phase 3)Study completedNCT02115204
What this trial is testing

4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF

Who this might be right for
Breast Cancer
West German Study Group 2,011
Early research (Phase 1)Study completedNCT00002866
What this trial is testing

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast CancerNeutropenia
NCIC Clinical Trials Group 50
Testing effectiveness (Phase 2)Ended earlyNCT01123473
What this trial is testing

Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionGastric Cancer
European Organisation for Research and Treatment of Cancer - EORTC 29
Large-scale testing (Phase 3)Active Not RecruitingNCT00798070
What this trial is testing

Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients

Who this might be right for
Breast Cancer
Karolinska University Hospital 2,017
Testing effectiveness (Phase 2)Study completedNCT02438865
What this trial is testing

Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.

Who this might be right for
Neoplasm, UreterNeoplasm, Bladder
Mansoura University 74
Testing effectiveness (Phase 2)Study completedNCT06513364
What this trial is testing

Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Beijing Wehand-Bio Pharmaceutical Co., Ltd 40
Load More Results